Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between Signos and Calibrate for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Signos focuses on continuous glucose monitoring at $127/month with a rating of 7.8/10. Calibrate also provides both semaglutide and tirzepatide at $199/month with a 8.5/10 rating.
The price difference of $72/month is significant - Signos is the more budget-friendly option, while Calibrate positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | Signos | Calibrate |
|---|---|---|
| Monthly Price | $127 | $199 |
| Rating | 7.8/10 | 8.5/10 |
| Medications | continuous glucose monitoring | semaglutide, tirzepatide |
| Insurance Accepted | No | Yes |
| Support Hours | In-app dietitian chat; hours not published | Not published |
| Live Chat | Available | No |
| Free Shipping | Yes | No |
| Shipping Speed | Free shipping; six-month plans ship in three-month bundles | Prescriptions filled through your pharmacy |
| Mobile App | Available | Available |
| Dedicated Coach | Included | Included |
| Follow-up Frequency | Continuous glucose data with in-app dietitian support | 1:1 video coaching throughout the Metabolic Reset programme |
| Money-back Guarantee | 30-day results guarantee - if you do not learn something new about how your body loses weight, a senior coach audits your data free (stated as a $250 value) | None published |
| Cancellation Policy | Subscription plans; cancellation terms apply even if HSA/FSA reimbursement is refused | Programme based; terms not published |

